An opioid-related alleged class action lawsuit has been filed against Walmart Inc., which is charging it with increasing its pharmacy revenue by knowingly filling thousands of invalid prescriptions.
The lawsuit was filed Wednesday in Wilmington District Court in Richard Stanton v. Walmart Inc. et al. from their pharmacists. The trial was first reported by the blog D&O Diary.
Walmart said in a statement, "We take these issues seriously. We do not agree with the allegations in the complaint and we will defend this issue strongly.
In an Echo from the Department of Justice complaint, the lawsuit, which accuses the company of violating federal security laws, Walmart's its pharmacy revenue. , and failed to disclose that the "knowingly archived prescription issued by so-called" pill-mill "prescribers"; filled thousands of recipes "that displayed obvious red flags, including dangerous cocktails of drugs"; and that company executives made it difficult for Walmart pharmacists to meet their legal obligations by forcing them to fulfill as many orders as possible.
The lawsuit states that Walmart's share price fell $ 2.75 per share, or 1
It was filed on behalf of shareholders who purchased the company's securities between March 30, 2016 and December 22, 2020.
In a statement issued after the Justice Department filed, Walmart had said, "The Department of Justice's investigation is troubled by historic ethical violations, and this lawsuit is based on a legal theory that illegally forces pharmacists to come between patients and their doctors, and is full of actual inaccuracies and cherry voices. picked documents taken out of context. "
In October, Walmart had filed a lawsuit against the Department of Justice and the Drug Enforcement Administration W almart Inc. against the DOJ, et al ., And asks the U.S. District Court in Sherman, Texas to clarify the roles and responsibilities of pharmacists and pharmacies under the Controlled Substances Act. A hearing on an action for dismissal of the case is scheduled for Tuesday.